secwatch.observer — SEC 8-K summary
======================================

Issuer:     Cardio Diagnostics Holdings, Inc. (CDIO)
CIK:        0001870144
Form:       8-K
Filed at:   2022-08-26T23:59:59+00:00
Accession:  0001079973-22-001040
Event type: m_and_a
Sentiment:  neutral
Materiality: 0.55
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Mana Capital provides investor presentation for proposed Cardio Diagnostics merger
--------------------------------------------------------------------------------

- Investor presentation first made available on August 26, 2022, for the business combination with Cardio Diagnostics.
- Merger Agreement entered May 27, 2022; Cardio to become wholly owned subsidiary of Mana, renamed Cardio Diagnostics Holdings Inc.
- Presentation will be used to solicit stockholder approval; Form S-4 proxy/prospectus filed with SEC.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1870144/000107997322001040/0001079973-22-001040-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1870144/000107997322001040/mana_8k-082622.htm
  HTML page:      https://secwatch.observer/filing/0001079973-22-001040

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer